DSP Clinical Research Founder and President Darlene Panzitta to Present Case Study on CRO Use of ePRO Solutions in eClinical Trials at Top ePRO Industry Conference
PARSIPPANY, NJ, March 8, 2010 –
DSP Clinical Research (DSP)’s visionary founder and top executive Darlene Panzitta continues to promote best practices in the CRO-sponsor relationship for eClinical trials. DSP is a full service CRO that uses innovative approaches to successfully manage Phase I-IV clinical studies.
Ms. Panzitta will offer an informative, insightful case study on the use of the SitePad Tablet, an innovative ePRO device used to collect patient data in clinical trials, at the 2010 U.S. PRO and ePRO Conference sponsored by PHT Corporation.
Ms. Panzitta said, “So many small to mid-size pharmaceutical and biotech sponsors choose DSP for Phase I through IV clinical studies because we tap into innovative technologies that allow them to conduct clinical trials on time and on budget. ePRO is an excellent example of an innovative technology.”
The meeting takes place March 16-18 in Paradise Valley, Arizona. Ms. Panzitta will join other industry experts for a dynamic and participatory meeting highlighted by a comprehensive agenda of PRO experts, global pharmaceutical case studies, and a distinguished keynote presentation by Kerri Nelen, Managing Editor of Applied Clinical Trials Magazine.
Ms. Panzitta continued, “CROs need to find ways to help sponsors capture the voice of the clinical trial patient direct and without distortion. I’ll present a case study to describe how we used ePRO to enable faster, more accurate data collection.”
About DSP Clinical
DSP is a CRO that specializes in small to mid-size pharmaceutical and biotechnology company clinical trial management from setup to NDA submission. DSP has managed and/or monitored more than 50 Phase I – IV clinical trials in various therapeutic areas, with15 NDAs and 3 PMAs. DSP has developed proprietary proven internal SOPs and QA metrics to ensure that quality systems are in place and rigorously followed during every client’s clinical study. For more information on DSP, visit www.www.dspclinical.com, or call 973-265-1060.
Contact: Brenda Nashawaty, Nashawaty Communications, Brenda@nashawaty.com, 617-688-3253.